Results 191 to 200 of about 73,134 (225)

A Humanized Anti‐gD Broadly Neutralizing Antibody Confers Complete Post‐Exposure Protection against Pseudorabies Virus

Advanced Science, EarlyView.
Pseudorabies virus (PRV), an emerging zoonotic α‐herpesvirus, causes life‐threatening human encephalitis. We identified a broad‐spectrum neutralizing antibody 6F7 targeting PRV gD. It blocks gD‐Nectin‐1 binding and membrane fusion, inhibiting replication across all PRV variants, representing a promising candidate for anti‐PRV therapy.
Yue Sun, Jianbo Liu, Shi‐Jia Xu, Meng‐Xin Wang, Hongliang Zhang, Yanhe Zhang, Zhi‐Jun Tian, Jin‐Mei Peng, Xin Yin, Tong‐Qing An, Xue‐Hui Cai, Yan‐Dong Tang   +11 more
wiley   +1 more source

RNA biomarkers in spinal muscular atrophy: enhancing pathogenesis understanding and guiding precision medicine. [PDF]

Cell Mol Life Sci
Alberti C, Berardinelli A, Comi GP, Ottoboni L, Corti S.   +4 more
europepmc   +1 more source

A Millimeter‐Scale Implantable Magneto–Mechano–Electric Transducer Based on BTO Piezoelectric Ceramics for Remote Wireless Electrical Stimulation of Injured Sciatic Nerves

Advanced Science, EarlyView.
We report a fully wireless, circuit‐free neural stimulator built on a millimetric magneto‐mechano‐electric (MME) cantilever transducer (3 × 10 × 5 mm) with a barium titanate (BTO) piezoelectric ceramic core. Under low‐frequency alternating magnetic fields, the MME cantilever mechanically oscillates, inducing stress on the BTO element and thereby ...
Yijing Wang, Jingyu Tian, Zhe Xu, Cuiling Zhang, Jingen Wu, Ming Liu, Zhilu Ye, Xiaohui Zhang   +7 more
wiley   +1 more source

Diagnostic Pitfalls in Adult-Onset Spinal Muscular Atrophy Type 4: When Incidental Lumbar Stenosis Confounds the Clinical Picture. [PDF]

Cureus
Rafique S, Rafiq I.
europepmc   +1 more source

Pathological Mechanism‐Inspired Biomimetic Nano‐Senotherapy for Reversing Experimental Atherosclerosis in ApoE−/− Mice

Advanced Science, EarlyView.
The biomimetic self‐assembly nanomedicine reversing atherosclerosis via senotherapy strategy. ABSTRACT The greatest challenge in atherosclerosis (AS) management lies in achieving lesion reversal, not merely slowing progression. Senescent cell accumulation—driven by continuous generation and apoptotic resistance—perpetuates plaque pathology and ...
Yuhan Tian, Yanrui Yang, Qiuyu Li, Ying Hu, Qin Hu, Shasha Ran, Siyu Zhou, Xiujuan Yang, Shanshan Li, Qixiong Zhang   +9 more
wiley   +1 more source

TMBIM6 enhances dopaminergic neuron survival by modulating the IRE1a pathway in Parkinson's disease. [PDF]

Cell Death Dis
Ahumada-Montalva P, Muñoz-Carvajal F, Bórquez-Macaya S, Arévalo-Ramírez N, Cisternas-Olmedo M, Jerez C, Urbina-Muñoz V, Gomez W, Urrutia PJ, Hirsch EC, Ahumada M, Barrias P, Muñoz-Yañez C, Herrera-Vásquez A, Arriagada G, Woehlbier U, Calegaro-Nassif M, Sanhueza M, Vidal RL, Rojas-Rivera D.   +19 more
europepmc   +1 more source

Amyotrophic Lateral Sclerosis (ALS) Genetics and Microbiota: A Comprehensive Review. [PDF]

Int J Mol Sci
Kurdi MA, Alotaibi H, Alkhuraymi AT, Aldahery LN, Alhawaj AF, Aldali HJ.   +5 more
europepmc   +1 more source

Considering prediagnostic environmental modifiers of progression in amyotrophic lateral sclerosis. [PDF]

BMJ Neurol Open
Chalitsios CV, Turner MR.
europepmc   +1 more source

Taming the "death receptor": translating the first-in-class p75^NTR modulator LM11A-31 from basic biology, across broad preclinical models, to clinical proof-of-concept. [PDF]

J Transl Med
Langness VF, Simmons DA, Kaur S, Massa SM, Longo FM.   +4 more
europepmc   +1 more source